The federal government is prepared to help fund states’ efforts to combat opioid addiction—but medical marijuana won’t be a part of it.
The Substance Abuse and Mental Health Services Administration (SAMHSA), an agency within the Department of Health and Human Services, said that it is barring money from several grant programs to support opioid addiction treatment to be used on medical cannabis.
“We felt that it was time to make it clear we did not want individuals receiving funds for treatment services to be exposed to marijuana and somehow given the impression that it’s a treatment,” said Dr. Elinore McCance-Katz, the assistant secretary for Mental Health and Substance Use, as quoted by the Associated Press.
The Associated Press reported that federal officials held calls with state leaders last week to detail the rules, which apply to three different grant programs offered to states in support of opioid and alcohol abuse treatment. Under the restrictions, the grant money cannot be used to purchase marijuana or to authorize cannabis treatment.
The restrictions do not, however, apply to grants from other federal agencies for research on medical marijuana, according to the Associated Press.
Treating Addiction With Cannabis
The decision is the latest reminder